Day: August 13, 2024

Kytopen Receives Prestigious Phase II SBIR Award of $1.6M from the NIAID/NIH to Support Pivotal In Vivo Studies of Engineered Natural Killer Cells

Kytopen awarded competitive phase II SBIR fast-track funding for "Non-Activated Natural Killer Cell Engineering for Enhanced Cytotoxic Potential" program.Funding to...

The Galien Foundation Announces 2024 Prix Galien USA Nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup”

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,...

error: Content is protected !!